Výsledky vyhledávání - "Sara Licitra"

Differences in Efficacy and Safety Between Capecitabine and Infusional 5-Fluorouracil When Combined With Irinotecan for the Treatment of Metastatic Colorectal Cancer

Autor: Giammaria Fiorentini, Francesco Montagnani, Camillo Aliberti, Antonella Chiriatti, Sara Licitra

Publikováno v: Clinical Colorectal Cancer. 9:243-247

Background Capecitabine is an oral fluoropyrimidine that is shown to have similar efficacy to 5-fluorouracil (5-FU) when used both alone and in combination with oxaliplatin in the treatment of colorectal cancer (CRC). Capecitabine and irinotecan comb

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62d7afb2fdfad663094b563faa6631f6
https://doi.org/10.3816/ccc.2010.n.036

Zobrazit plný text záznamu

Taxanes in the elderly: Can we gain as much and be less toxic?

Autor: Marta Pestrin, Sara Licitra, Angelo Di Leo, Laura Biganzoli, Elena Zafarana, Erica Moretti

Publikováno v: Critical Reviews in Oncology/Hematology. 70:262-271

Taxanes are very effective agents in several types of cancer. However, their activity is counterbalanced by side effects that could represent a limitation of their use in older cancer patients. This review aims at evaluating whether or not there are

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fea9a10b5eef8b0964128afac4b9e9ea
https://doi.org/10.1016/j.critrevonc.2008.07.017

Zobrazit plný text záznamu

Topoisomerase II alpha as a marker predicting anthracyclines’ activity in early breast cancer patients: Ready for the primetime?

Autor: Denis Larsimont, Marta Pestrin, Sara Licitra, Wederson M. Claudino, Angelo Di Leo, Laura Biganzoli

Publikováno v: European Journal of Cancer. 44:2791-2798

Purpose This manuscript reviews and discusses results from randomised clinical studies evaluating topoisomerase II alpha (topo II) as a marker predicting anthracyclines’ activity in early breast cancer patients. Methods A Medline search has led to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::975daccbb437aa68e1a358e8d1fd0a45
https://doi.org/10.1016/j.ejca.2008.09.014

Zobrazit plný text záznamu

Using specific cytotoxics with a targeted mind

Autor: Sara Licitra, Wederson M. Claudino, Laura Biganzoli, Marta Pestrin, Angelo Di Leo

Publikováno v: Breast (Edinburgh, Scotland). 16

It is largely known that clinical activity of a given cytotoxic agent may vary between different patients. This suggests that breast cancer sub-types can be identified within the endocrine-resistant cohort, each of them with a specific degree of sens

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b40c155c5b132273e66c60023da2c43
https://pubmed.ncbi.nlm.nih.gov/17720501

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání